FOLLOWING THE grant of Emergency Use Authorization (EUA) to Covid-19 treatment drug Ronapreve, the Department of Health (DOH) said it will need a recommendation from the Health Technology Assessment Council (HTAC) and Living CPG (Clinical Practice Guidelines) before the government procures the medicine.
